Organogenesis
This article was originally published in The Gray Sheet
Executive Summary
Shipments of Apligraf bi-layered, living skin substitute to Novartis Pharma AG will be suspended until the two firms can reach an "equitable resolution" over how to restructure their supply arrangement. The companies have been in discussions since July over amending the relationship; however, no agreement has been reached and talks are ongoing (1"The Gray Sheet" July 15, 2002, p. 15). As a result of the halted shipments, Organogenesis will place 110 of its employees on furlough for up to two weeks until a resolution is met...